News
About INmune Bio Inc. INmune Bio Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback